MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 51 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 4.16 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Praetorian Wealth Management, Inc. | 200,000 | $118,400 | 0.04% |
| Atlas Brown,Inc. | 43,500 | $25,752 | 0.01% |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $9,523 | 0.01% |
| Fidelis Capital Partners, LLC | 38,590 | $22,845 | 0.01% |
| Cambria Investment Management, L.P. | 171,570 | $101,569 | 0.01% |
| Corundum Group, Inc. | 19,600 | $11,603 | 0.01% |
| Bridgecreek Investment Management, LLC | 30,000 | $17,760 | 0.00% |
| XTX Topco Ltd | 39,544 | $23,410 | 0.00% |
| WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC | 14,000 | $8,288 | 0.00% |
| NWAM LLC | 40,000 | $23,680 | 0.00% |
| LVZ, Inc. | 16,343 | $9,675 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 940,602 | $556,836 | 0.00% |
| Western Wealth Management, LLC | 25,050 | $14,830 | 0.00% |
| SeaCrest Wealth Management, LLC | 12,850 | $7,607 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,223 | $3,092 | 0.00% |
| NORTHERN TRUST CORP | 59,846 | $35,429 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 32,877 | $19,463 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 291,229 | $172,438 | 0.00% |
| STATE STREET CORP | 120,252 | $71,189 | 0.00% |
This page lists MYMD PHARMACEUTICALS INC's shareholders in Q3 2023. To view MYMD PHARMACEUTICALS INC's shareholder history, click here.